Human TNNI3/CMD1FF/CMD2A ORF/cDNA clone-Lentivirus particle (NM_000363)
Cat. No.: vGMLP002894
Pre-made Human TNNI3/CMD1FF/CMD2A Lentiviral expression plasmid for TNNI3 lentivirus packaging, TNNI3 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.
Go to
Cardiac Troponin I/TNNI3/TNNI3/CMD1FF products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
| Catalog No. | Product Name | lentivirus Grade | lentivirus quantity |
|---|---|---|---|
| vGMLP002894 | Human TNNI3 Lentivirus particle | Pilot Grade | 1.0E+8TU |
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| Research Grade | 1.0E+8TU | ||
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| GMP-like Grade | inquiry | ||
| GMP Grade | inquiry |
Product Description
| Catalog ID | vGMLP002894 |
| Gene Name | TNNI3 |
| Accession Number | NM_000363 |
| Gene ID | 7137 |
| Species | Human |
| Product Type | Lentivirus particle (overexpression) |
| Insert Length | 633 bp |
| Gene Alias | CMD1FF,CMD2A,CMH7,cTnI,RCM1,TNNC1 |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGGCGGATGGGAGCAGCGATGCGGCTAGGGAACCTCGCCCTGCACCAGCCCCAATCAGACGCCGCTCCTCCAACTACCGCGCTTATGCCACGGAGCCGCACGCCAAGAAAAAATCTAAGATCTCCGCCTCGAGAAAATTGCAGCTGAAGACTCTGCTGCTGCAGATTGCAAAGCAAGAGCTGGAGCGAGAGGCGGAGGAGCGGCGCGGAGAGAAGGGGCGCGCTCTGAGCACCCGCTGCCAGCCGCTGGAGTTGGCCGGGCTGGGCTTCGCGGAGCTGCAGGACTTGTGCCGACAGCTCCACGCCCGTGTGGACAAGGTGGATGAAGAGAGATACGACATAGAGGCAAAAGTCACCAAGAACATCACGGAGATTGCAGATCTGACTCAGAAGATCTTTGACCTTCGAGGCAAGTTTAAGCGGCCCACCCTGCGGAGAGTGAGGATCTCTGCAGATGCCATGATGCAGGCGCTGCTGGGGGCCCGGGCTAAGGAGTCCCTGGACCTGCGGGCCCACCTCAAGCAGGTGAAGAAGGAGGACACCGAGAAGGAAAACCGGGAGGTGGGAGACTGGCGCAAGAACATCGATGCACTGAGTGGAATGGAGGGCCGCAAGAAAAAGTTTGAGAGCTGA |
| ORF Protein Sequence | MADGSSDAAREPRPAPAPIRRRSSNYRAYATEPHAKKKSKISASRKLQLKTLLLQIAKQELEREAEERRGEKGRALSTRCQPLELAGLGFAELQDLCRQLHARVDKVDEERYDIEAKVTKNITEIADLTQKIFDLRGKFKRPTLRRVRISADAMMQALLGARAKESLDLRAHLKQVKKEDTEKENREVGDWRKNIDALSGMEGRKKKFES |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-T20186-Ab | Anti-TNNI3 monoclonal antibody |
| Target Antigen | GM-Tg-g-T20186-Ag | TNNI3 protein |
| ORF Viral Vector | pGMLP002894 | Human TNNI3 Lentivirus plasmid |
| ORF Viral Vector | vGMLP002894 | Human TNNI3 Lentivirus particle |
Target information
| Target ID | GM-T20186 |
| Target Name | Cardiac Troponin I/TNNI3 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
7137 |
| Gene ID |
100034065 (Equus caballus), 21954 (Mus musculus), 29248 (Rattus norvegicus), 403566 (Canis lupus familiaris) 493744 (Felis catus), 511094 (Bos taurus), 698470 (Macaca mulatta), 7137 (Homo sapiens) |
| Gene Symbols & Synonyms | TNNI3,Tnni3,Tn1,cTnI,TnI,cTNI,CMH7,RCM1,CMD2A,TNNC1,CMD1FF |
| Target Alternative Names | CMD1FF,CMD2A,CMH7,Cardiac Troponin I,Cardiac troponin I,RCM1,TNNC1,TNNI3,Tn1,TnI,Tnni3,Troponin I,cTNI,cTnI,cardiac muscle |
| Uniprot Accession |
P08057,P19429,P23693,P48787,Q5PYI0,Q863B6,Q8MKD5
Additional SwissProt Accessions: Q5PYI0,P48787,P23693,Q8MKD5,Q863B6,P08057,P19429 |
| Uniprot Entry Name | |
| Protein Sub-location | Introcelluar Protein |
| Category | Therapeutics Target, Diagnostics Biomarker |
| Disease | |
| Disease from KEGG | cAMP signaling pathway, Adrenergic signaling in cardiomyocytes, Hypertrophic cardiomyopathy, Dilated cardiomyopathy |
| Gene Ensembl | ENSECAG00000017232, ENSMUSG00000035458, ENSBTAG00000002515, ENSG00000129991 |
| Target Classification |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


